Mira Pharmaceuticals (MIRA) Current Assets (2022 - 2025)
Mira Pharmaceuticals (MIRA) posted Current Assets of $11.1 million for Q4 2025, up 45.54% sequentially from $7.6 million in Q3 2025, and up 282.95% YoY from $2.9 million in Q4 2024.
Mira Pharmaceuticals (MIRA) Current Assets (2022 - 2025) Analysis & Trends
Mira Pharmaceuticals has reported Current Assets for 4 years, with the latest figure at $11.1 million in Q4 2025.
- Quarterly Current Assets rose 282.95% year-over-year to $11.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $11.1 million (up 282.95% YoY) and the FY2025 annual result came in at $11.1 million, up 282.95% from the prior year.
- Current Assets climbed to $11.1 million in Q4 2025 per MIRA's latest filing, from $7.6 million in the prior quarter.
- Over five years, Current Assets peaked at $11.1 million in Q4 2025 and troughed at $420719.0 in Q2 2023.
- A 4-year average of $4.0 million and a median of $3.7 million in 2024 frame the typical range for Current Assets.
- The sharpest annual moves came in 2023 and 2025: Current Assets soared 882.64% in 2023, then sank 63.25% in 2025.
- Over 4 years, Current Assets stood at $494405.0 in 2022, then jumped by 882.64% to $4.9 million in 2023, then tumbled by 40.56% to $2.9 million in 2024, then soared by 282.95% to $11.1 million in 2025.
- According to Business Quant data, Current Assets over the past three periods registered $11.1 million, $7.6 million, and $832879.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn | 59.77 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn | 33.67 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn | 36.68 Bn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn | 27.35 Bn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn | 27.97 Bn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn | 34.96 Bn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn | 13.95 Bn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn | 41.36 Bn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn | 23.56 Bn |
| 10 | Mira Pharmaceuticals | 18.47 Mn | 7.44 Mn | - | 11.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 11.06 Mn |
| Sep 30, 2025 | 7.60 Mn |
| Jun 30, 2025 | 832,879.00 |
| Mar 31, 2025 | 1.36 Mn |
| Dec 31, 2024 | 2.89 Mn |
| Sep 30, 2024 | 4.23 Mn |
| Mar 31, 2024 | 3.71 Mn |
| Dec 31, 2023 | 4.86 Mn |
| Sep 30, 2023 | 6.07 Mn |
| Jun 30, 2023 | 420,719.00 |
| Dec 31, 2022 | 494,405.00 |